Amicus Therapeutics Announces Closing Of Underwritten Offering Of Common Stock
July 18, 2017 at 12:18 PM EDT
Amicus Therapeutics, a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced the closing of its previously announced offering of common stock.